Candidaarteritis in kidney transplant recipients: case report and review of the literature

2015 ◽  
Vol 17 (3) ◽  
pp. 449-455 ◽  
Author(s):  
A. Dębska-Ślizień ◽  
Ł. Chrobak ◽  
B. Bzoma ◽  
A. Perkowska ◽  
D. Zadrożny ◽  
...  
Author(s):  
Gulsah Sasak ◽  
Ebru Zemheri ◽  
Abdullah Ozkok ◽  
Kubra Aydın Bahat ◽  
Sabahat Alısır Ecder ◽  
...  

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Masahiro Tomonari ◽  
Mariko Shimada ◽  
Yasuyuki Nakada ◽  
Izumi Yamamoto ◽  
Munenari Itoh ◽  
...  

Abstract Background Sebaceous carcinoma is a rare but progressive malignant skin cancer, and the incidence is approximately five times higher in post-transplant patients than in people who have not received kidney transplants. Sebaceous carcinoma is sometimes found concurrently with visceral cancers and a genetic abnormality, Muir–Torre syndrome. We report the case of a female kidney transplant recipient with sebaceous carcinoma concurrent with colon cancer 10 years after transplantation. Case presentation A 43-year-old woman was admitted due to a rapidly progressive tumor on her head. Histologically, the tumor was diagnosed as sebaceous carcinoma. We diagnosed her with Muir–Torre syndrome based on the following evidence: 1) high prevalence of microsatellite instability in gene locus assay, 2) absence of mismatch repair proteins in the sebaceous carcinoma on immunohistochemical analysis, and 3) a genetic mutation of 1226_1227delAG in the MSH2 exon 7 in the lesion detected by DNA sequencing analysis. Several reports have shown an association between immunosuppressive agents and latent Muir–Torre syndrome progression. Therefore, the progression of colon cancer in this case originated from her genetic mutation for Muir–Torre syndrome and long-term use of immunosuppressive agents. Conclusion This case report not only highlights the importance of adequate diagnosis and therapy for Muir–Torre syndrome, but also suggests the further prevention of the development of malignant tumors in kidney transplant recipients. Physicians should be mindful that sebaceous carcinoma in kidney transplant recipients is highly concurrent with Muir–Torre syndrome.


2010 ◽  
Vol 3 (2) ◽  
pp. 73-77 ◽  
Author(s):  
Kate Bramham ◽  
Liz Lightstone ◽  
John Taylor ◽  
Nadey S Hakim ◽  
Kate Harding ◽  
...  

Seventy-three pregnancies in 43 women with SPK have now been described by the US National Transplantation Pregnancy Registry (NTPR) (established in 1991), which contains self-reported data from questionnaires and hospital records. These women have high rates of complications despite normoglycaemia and restoration of renal function. We describe the pregnancies of three SPK recipients in the UK managed in joint renal obstetric clinics and discuss the antenatal and postnatal complications specific to SPK transplants.


2018 ◽  
Vol 20 (2) ◽  
pp. e12836 ◽  
Author(s):  
Jose F. Camargo ◽  
Jacques Simkins ◽  
Denise C. Schain ◽  
A. Adrian Gonzalez ◽  
Maria L. Alcaide ◽  
...  

2018 ◽  
Vol 22 (7) ◽  
pp. e13274 ◽  
Author(s):  
Kenice Ferguson-Paul ◽  
Catherine Park ◽  
Sandra Childress ◽  
Sandra Arnold ◽  
Bettina Ault ◽  
...  

2019 ◽  
Vol 12 (5) ◽  
pp. 745-747
Author(s):  
Quan Yao Ho ◽  
Chieh Suai Tan ◽  
Siew Yee Thien ◽  
Terence Kee ◽  
Maciej Piotr Chlebicki

Abstract Adenovirus is an important cause of haemorrhagic cystitis in kidney transplant recipients. The optimal treatment for adenovirus-associated haemorrhagic cystitis (AAHC) is unknown. Intravenous cidofovir may be effective, but nephrotoxicity is a major concern. The use of intravesical cidofovir for viral haemorrhagic cystitis has been reported in haematopoietic stem cell transplant recipients and may be associated with a lower risk of nephrotoxicity, but its use has not been reported in kidney transplant recipients. We report the use of intravesical cidofovir for the treatment of AAHC in a kidney transplant recipients, along with a review of the literature.


Sign in / Sign up

Export Citation Format

Share Document